Optas, LLC Becton Dickinson & CO Transaction History

Optas, LLC

$574 Million
Q3 2025

A detailed history of Optas, LLC transactions in Becton Dickinson & CO stock. As of the latest transaction made, Optas, LLC holds 2,370 shares of BDX stock, worth $452,622. This represents 0.08% of its overall portfolio holdings.

Number of Shares

2,370

Previous 2,138 10.85%

Holding current value

$452,622

Previous $368,000 20.38%

% of portfolio

0.08%

Previous 0.07%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2025 Oct 15, 2025	BUY	$172.41 - $199.66 $39,999 - $46,321	232 Added 10.85%	2,370 $443,000
Q2 2025 Jul 23, 2025	SELL	$165.15 - $226.42 $49,545 - $67,926	-300 Reduced 12.31%	2,138 $368,000
Q1 2025 Apr 17, 2025	SELL	$222.79 - $249.08 $22,501 - $25,157	-101 Reduced 3.98%	2,438 $558,000
Q4 2024 Jan 24, 2025	SELL	$220.02 - $243.75 $146,533 - $162,337	-666 Reduced 20.78%	2,539 $576,000
Q3 2024 Oct 29, 2024	BUY	$221.47 - $242.41 $58,025 - $63,511	262 Added 8.9%	3,205 $772,000

Q2 2024 Jul 25, 2024	BUY	$225.07 - $246.17 $18,680 - $20,432	83 Added 2.9%	2,943 $687,000
Q1 2024 Apr 17, 2024	SELL	$233.45 - $247.73 $4,435 - $4,706	-19 Reduced 0.66%	2,860 $707,000
Q4 2023 Jan 25, 2024	SELL	$232.24 - $267.23 $8,128 - $9,353	-35 Reduced 1.2%	2,879 $701,000
Q3 2023 Oct 31, 2023	SELL	$254.9 - $283.59 $27,784 - $30,911	-109 Reduced 3.61%	2,914 $753,000
Q2 2023 Jul 20, 2023	SELL	$238.39 - $265.32 $2,383 - $2,653	-10 Reduced 0.33%	3,023 $798,000
Q1 2023 Apr 17, 2023	SELL	$229.71 - $259.35 $153,446 - $173,245	-668 Reduced 18.05%	3,033 $750,000
Q4 2022 Jan 27, 2023	SELL	$218.29 - $256.91 $11,132 - $13,102	-51 Reduced 1.36%	3,701 $941,000
Q3 2022 Oct 31, 2022	BUY	$51.03 - $264.23 $2,041 - $10,569	40 Added 1.08%	3,752 $837,000
Q2 2022 Aug 01, 2022	BUY	$234.74 - $275.42 $16,197 - $19,003	69 Added 1.89%	3,712 $915,000
Q1 2022 Apr 26, 2022	BUY	$243.64 - $270.48 $3,898 - $4,327	16 Added 0.44%	3,643 $969,000
Q4 2021 Jan 26, 2022	BUY	$230.08 - $250.94 $230 - $250	1 Added 0.03%	3,627 $912,000
Q3 2021 Oct 14, 2021	BUY	$232.72 - $256.47 $1,163 - $1,282	5 Added 0.14%	3,626 $891,000
Q2 2021 Jul 27, 2021	SELL	$232.65 - $254.58 $74,913 - $81,974	-322 Reduced 8.17%	3,621 $881,000
Q1 2021 Apr 19, 2021	BUY	$232.09 - $256.88 $84,944 - $94,018	366 Added 10.23%	3,943 $958,000
Q4 2020 Jan 27, 2021	SELL	$221.92 - $245.94 $391,244 - $433,592	-1,763 Reduced 33.01%	3,577 $895,000
Q3 2020 Oct 23, 2020	BUY	$215.77 - $276.76 $578,910 - $742,547	2,683 Added 100.98%	5,340 $1.24 Million
Q2 2020 Jul 31, 2020	SELL	$219.9 - $263.41 $100,274 - $120,114	-456 Reduced 14.65%	2,657 $635,000
Q1 2020 Apr 14, 2020	BUY	$195.69 - $279.01 $7,631 - $10,881	39 Added 1.27%	3,113 $715,000
Q4 2019 Feb 14, 2020	BUY	$236.45 - $266.82 $726,847 - $820,204	3,074 New	3,074 $836,000

Others Institutions Holding BDX

# of Institutions

1,717

Shares Held

257M

Call Options Held

1.01M

Put Options Held

544K

View Full List

About BECTON DICKINSON & CO

Ticker BDX
Exchange NYSE
Sector Healthcare
Industry Medical Instruments & Supplies
Shares Outstandng 285,195,008
Market Cap $54.5B
Description
Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. The company's BD Medical segment offers peripheral intravenou...

More about BDX

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Optas, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Optas, LLC with notifications on news.

Account